Zhi-Dong Zhou (Zhi Dong Zhou)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Combination Therapy

Mild Cognitive Impairment

Top Venues

Journal of translational medicine

International journal of molecular sciences

Science signaling

Translational neurodegeneration

This page only lists publications with an associated author ORCID identifier.

Publications

Ling Xiao Yi, Eng King Tan, Zhi-Dong Zhou
Passive immunotherapy for Alzheimer's disease: challenges & future directions. Journal of translational medicine 22 (1) (2024)
Ling Xiao Yi, Eng King Tan, Zhi-Dong Zhou
Passive immunotherapy for Alzheimer's disease: challenges & future directions. Journal of translational medicine 22 (1) (2024)
Ling Xiao Yi, Eng King Tan, Zhi-Dong Zhou
Tyrosine Hydroxylase Inhibitors and Dopamine Receptor Agonists Combination Therapy for Parkinson's Disease. International journal of molecular sciences 25 (9) (2024)
Ling Xiao Yi, Eng King Tan, Zhi-Dong Zhou
Tyrosine Hydroxylase Inhibitors and Dopamine Receptor Agonists Combination Therapy for Parkinson's Disease. International journal of molecular sciences 25 (9) (2024)
Ling Xiao Yi, Eng King Tan, Zhi-Dong Zhou
Tyrosine Hydroxylase Inhibitors and Dopamine Receptor Agonists Combination Therapy for Parkinson's Disease. International journal of molecular sciences 25 (9) (2024)
Ling Xiao Yi, Eng King Tan, Zhi-Dong Zhou
Passive immunotherapy for Alzheimer's disease: challenges & future directions. Journal of translational medicine 22 (1) (2024)
Zhi-Dong Zhou, Ling Xiao Yi, Dennis Qing Wang, Tit Meng Lim, Eng King Tan
Role of dopamine in the pathophysiology of Parkinson's disease. Translational neurodegeneration 12 (1) (2023)
Zhi-Dong Zhou, Wuan Ting Saw, Patrick Ghim Hoe Ho, Zhi Wei Zhang, Li Zeng, Ya Yin Chang, Alfred Xu Yang Sun, Dong Rui Ma, Hong Yan Wang, Lei Zhou, Kah Leong Lim, Eng-King Tan
The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis. Cellular and molecular life sciences : CMLS 79 (12) (2022)
Zhi-Wei Zhang, Haitao Tu, Mei Jiang, Sarivin Vanan, Sook Yoong Chia, Se-Eun Jang, Wuan-Ting Saw, Zhi-Wei Ong, Dong-Rui Ma, Zhi-Dong Zhou, Jie Xu, Kai-Hua Guo, Wei-Ping Yu, Shuo-Chien Ling, Richard A Margolin, Daniel G Chain, Li Zeng, Eng-King Tan
The APP intracellular domain promotes LRRK2 expression to enable feed-forward neurodegenerative mechanisms in Parkinson's disease. Science signaling 15 (748) (2022)
Zhi-Dong Zhou, Thevapriya Selvaratnam, Ji Chao Tristan Lee, Yin Xia Chao, Eng-King Tan
Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson's disease. Translational neurodegeneration 8 (2019)
Zhong-Can Chen, Wei Zhang, Ling-Ling Chua, Chou Chai, Rong Li, Lin Lin, Zhen Cao, Dario C Angeles, Lawrence W Stanton, Jian-He Peng, Zhi-Dong Zhou, Kah Leong Lim, Li Zeng, Eng King Tan
Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's disease. Science signaling 10 (488) (2017)